| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.82e-07 | 303 | 47 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | SMARCA4 SMARCC1 KDM2B SMARCD3 TCF4 ARID1B ZMIZ1 ATN1 SS18 EP300 | 5.84e-07 | 562 | 47 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | chromatin binding | SMARCA4 SMARCC1 SOX10 SMARCD3 TCF4 ARID1B MBD5 ZC3H4 EP300 BAHCC1 | 6.79e-06 | 739 | 47 | 10 | GO:0003682 |
| GeneOntologyMolecularFunction | oxoglutarate dehydrogenase (succinyl-transferring) activity | 3.24e-05 | 4 | 47 | 2 | GO:0004591 | |
| GeneOntologyMolecularFunction | thiamine pyrophosphate binding | 1.50e-04 | 8 | 47 | 2 | GO:0030976 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 1.93e-04 | 9 | 47 | 2 | GO:0016624 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SMARCA4 SMARCC1 KDM2B SMARCD3 TCF4 ARID1B ZMIZ1 ATN1 SS18 EP300 | 3.04e-04 | 1160 | 47 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.27e-04 | 140 | 47 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.36e-04 | 753 | 47 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.94e-04 | 582 | 47 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 4.00e-04 | 61 | 47 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ONECUT3 EP300 MYEF2 MEIS2 ARNT2 | 5.29e-04 | 1244 | 47 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ONECUT3 EP300 MYEF2 MEIS2 ARNT2 | 6.26e-04 | 1271 | 47 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 9.84e-04 | 83 | 47 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SMARCA4 SMARCC1 KDM2B SMARCD3 TCF4 ARID1B ZMIZ1 ATN1 SS18 EP300 | 1.03e-03 | 1356 | 47 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | nucleosome binding | 1.59e-03 | 98 | 47 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ONECUT3 EP300 MYEF2 MEIS2 ARNT2 | 1.80e-03 | 1459 | 47 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.41e-03 | 31 | 47 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.73e-03 | 33 | 47 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.83e-03 | 120 | 47 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 3.43e-03 | 37 | 47 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 5.25e-03 | 46 | 47 | 2 | GO:0050997 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 6.94e-03 | 323 | 47 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 7.11e-03 | 167 | 47 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 7.70e-03 | 56 | 47 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.69e-03 | 187 | 47 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 9.91e-03 | 560 | 47 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.03e-02 | 566 | 47 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.09e-02 | 67 | 47 | 2 | GO:0031492 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 6.57e-08 | 95 | 46 | 6 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 7.92e-08 | 98 | 46 | 6 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 8.93e-08 | 100 | 46 | 6 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.07e-07 | 103 | 46 | 6 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.67e-07 | 111 | 46 | 6 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 4.94e-07 | 29 | 46 | 4 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 6.31e-07 | 139 | 46 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 7.76e-07 | 144 | 46 | 6 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SMARCA4 SMARCC1 SOX10 TCF4 POU3F1 SSBP2 ZMIZ1 SSBP4 ONECUT3 SS18 TNFSF8 EP300 MEIS2 ARNT2 | 1.16e-06 | 1390 | 46 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.55e-06 | 162 | 46 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 2.28e-06 | 42 | 46 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 2.75e-06 | 44 | 46 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 5.01e-06 | 51 | 46 | 4 | GO:1902459 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.31e-06 | 54 | 46 | 4 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.05e-05 | 226 | 46 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.55e-05 | 242 | 46 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.55e-05 | 242 | 46 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 1.55e-05 | 22 | 46 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 2.03e-05 | 382 | 46 | 7 | GO:0030217 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 2.03e-05 | 24 | 46 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 2.04e-05 | 254 | 46 | 6 | GO:0000819 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 2.28e-05 | 540 | 46 | 8 | GO:1903706 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 2.64e-05 | 266 | 46 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.64e-05 | 266 | 46 | 6 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 2.74e-05 | 78 | 46 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ILF3 ATN1 ZC3H4 RIPPLY2 EP300 MYEF2 MEIS2 | 4.05e-05 | 1399 | 46 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 4.26e-05 | 429 | 46 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 4.28e-05 | 290 | 46 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 4.40e-05 | 88 | 46 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ILF3 ATN1 ZC3H4 RIPPLY2 EP300 MYEF2 MEIS2 | 4.46e-05 | 1413 | 46 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 5.24e-05 | 92 | 46 | 4 | GO:0045661 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 5.66e-05 | 614 | 46 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 5.94e-05 | 95 | 46 | 4 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 6.44e-05 | 458 | 46 | 7 | GO:0050863 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 7.02e-05 | 317 | 46 | 6 | GO:1903039 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SMARCA4 SOX10 KDM2B TCF4 POU3F1 ATN1 RIPPLY2 EP300 MYEF2 MEIS2 | 8.74e-05 | 1053 | 46 | 10 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of cell development | SMARCA4 SMARCC1 SOX10 SMARCD3 ARID1B FBN1 ZMIZ1 CDH5 EP300 MEIS2 | 1.21e-04 | 1095 | 46 | 10 | GO:0060284 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.33e-04 | 356 | 46 | 6 | GO:0098813 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.73e-04 | 537 | 46 | 7 | GO:0030098 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.83e-04 | 727 | 46 | 8 | GO:0032870 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 2.01e-04 | 51 | 46 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 2.03e-04 | 385 | 46 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 2.14e-04 | 389 | 46 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | myoblast differentiation | 2.38e-04 | 136 | 46 | 4 | GO:0045445 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | 2.56e-04 | 402 | 46 | 6 | GO:1901990 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.88e-04 | 143 | 46 | 4 | GO:0045739 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 3.09e-04 | 999 | 46 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 3.12e-04 | 146 | 46 | 4 | GO:2000779 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 3.18e-04 | 789 | 46 | 8 | GO:0002521 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 3.20e-04 | 594 | 46 | 7 | GO:0007346 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 3.36e-04 | 423 | 46 | 6 | GO:0002696 | |
| GeneOntologyBiologicalProcess | pyramidal neuron development | 3.74e-04 | 13 | 46 | 2 | GO:0021860 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 3.91e-04 | 614 | 46 | 7 | GO:0051249 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 4.12e-04 | 65 | 46 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 4.50e-04 | 447 | 46 | 6 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 4.61e-04 | 449 | 46 | 6 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 4.70e-04 | 68 | 46 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 5.01e-04 | 640 | 46 | 7 | GO:1903131 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 5.55e-04 | 465 | 46 | 6 | GO:0007059 | |
| GeneOntologyBiologicalProcess | positive regulation by host of viral transcription | 6.48e-04 | 17 | 46 | 2 | GO:0043923 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 6.99e-04 | 486 | 46 | 6 | GO:0007159 | |
| GeneOntologyBiologicalProcess | chromatin organization | 7.39e-04 | 896 | 46 | 8 | GO:0006325 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 8.09e-04 | 694 | 46 | 7 | GO:0002694 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 8.10e-04 | 1141 | 46 | 9 | GO:0045597 | |
| GeneOntologyBiologicalProcess | pyramidal neuron differentiation | 8.12e-04 | 19 | 46 | 2 | GO:0021859 | |
| GeneOntologyBiologicalProcess | T cell activation | 8.58e-04 | 701 | 46 | 7 | GO:0042110 | |
| GeneOntologyBiologicalProcess | head development | 8.71e-04 | 919 | 46 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 8.89e-04 | 509 | 46 | 6 | GO:0044772 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | 9.54e-04 | 516 | 46 | 6 | GO:1901987 | |
| GeneOntologyBiologicalProcess | 2-oxoglutarate metabolic process | 9.95e-04 | 21 | 46 | 2 | GO:0006103 | |
| GeneOntologyBiologicalProcess | central nervous system development | 1.14e-03 | 1197 | 46 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 1.18e-03 | 208 | 46 | 4 | GO:0009166 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 1.19e-03 | 741 | 46 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 1.28e-03 | 213 | 46 | 4 | GO:2000045 | |
| GeneOntologyBiologicalProcess | hemopoiesis | SMARCA4 SMARCC1 SMARCD3 ARID1B FBN1 ZMIZ1 TNFSF8 EP300 MEIS2 | 1.32e-03 | 1223 | 46 | 9 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of cell activation | 1.33e-03 | 756 | 46 | 7 | GO:0050865 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 1.35e-03 | 216 | 46 | 4 | GO:1901292 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 1.41e-03 | 25 | 46 | 2 | GO:2000114 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | AMBN SMARCA4 SMARCC1 KDM2B SMARCD3 ZMIZ1 RIPPLY2 EP300 MEIS2 | 1.71e-03 | 1269 | 46 | 9 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.72e-03 | 579 | 46 | 6 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.74e-03 | 580 | 46 | 6 | GO:0022407 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.81e-03 | 234 | 46 | 4 | GO:0006282 | |
| GeneOntologyBiologicalProcess | glycolytic process | 1.90e-03 | 110 | 46 | 3 | GO:0006096 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.90e-03 | 237 | 46 | 4 | GO:0019827 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.95e-03 | 1042 | 46 | 8 | GO:0009725 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.96e-03 | 239 | 46 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 2.03e-03 | 30 | 46 | 2 | GO:0032878 | |
| GeneOntologyBiologicalProcess | forebrain neuron development | 2.03e-03 | 30 | 46 | 2 | GO:0021884 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 2.05e-03 | 242 | 46 | 4 | GO:0098727 | |
| GeneOntologyBiologicalProcess | ADP catabolic process | 2.10e-03 | 114 | 46 | 3 | GO:0046032 | |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.17e-03 | 31 | 46 | 2 | GO:0060765 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 2.18e-03 | 246 | 46 | 4 | GO:1902806 | |
| GeneOntologyBiologicalProcess | purine nucleoside diphosphate catabolic process | 2.26e-03 | 117 | 46 | 3 | GO:0009137 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside diphosphate catabolic process | 2.26e-03 | 117 | 46 | 3 | GO:0009181 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 2.37e-03 | 119 | 46 | 3 | GO:0019364 | |
| GeneOntologyCellularComponent | npBAF complex | 8.13e-11 | 14 | 46 | 5 | GO:0071564 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 5.64e-09 | 30 | 46 | 5 | GO:0016514 | |
| GeneOntologyCellularComponent | nBAF complex | 3.66e-08 | 16 | 46 | 4 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.17e-06 | 96 | 46 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | GBAF complex | 3.57e-06 | 14 | 46 | 3 | GO:0140288 | |
| GeneOntologyCellularComponent | brahma complex | 3.57e-06 | 14 | 46 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | ATPase complex | 9.26e-06 | 129 | 46 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | chromatin | SMARCA4 SMARCC1 SOX10 SMARCD3 TCF4 POU3F1 ARID1B ZMIZ1 ONECUT3 SS18 EP300 MEIS2 ARNT2 | 1.19e-05 | 1480 | 46 | 13 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SMARCA4 SMARCC1 KDM2B CASC3 SMARCD3 TCF4 ARID1B SF3B4 SS18 WDR33 PRPF40A | 1.52e-04 | 1377 | 46 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | bBAF complex | 2.11e-04 | 10 | 46 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | nuclear matrix | 2.53e-04 | 140 | 46 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | oxoglutarate dehydrogenase complex | 2.57e-04 | 11 | 46 | 2 | GO:0045252 | |
| GeneOntologyCellularComponent | RSC-type complex | 4.88e-04 | 15 | 46 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | nuclear periphery | 5.40e-04 | 171 | 46 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | tricarboxylic acid cycle heteromeric enzyme complex | 7.09e-04 | 18 | 46 | 2 | GO:0045239 | |
| GeneOntologyCellularComponent | alpha-ketoacid dehydrogenase complex | 7.09e-04 | 18 | 46 | 2 | GO:0045240 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.27e-03 | 97 | 46 | 3 | GO:0005684 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 3.27e-06 | 298 | 18 | 8 | HP:0006494 | |
| HumanPheno | Short finger | 6.27e-06 | 325 | 18 | 8 | HP:0009381 | |
| HumanPheno | Hypoplasia of the phalanges of the toes | 7.99e-06 | 12 | 18 | 3 | HP:0010746 | |
| HumanPheno | Cryptorchidism | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 ARNT2 | 1.15e-05 | 780 | 18 | 11 | HP:0000028 |
| HumanPheno | Abnormal upper lip morphology | SMARCA4 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 1.42e-05 | 980 | 18 | 12 | HP:0000177 |
| HumanPheno | Abnormal spermatogenesis | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 1.50e-05 | 1190 | 18 | 13 | HP:0008669 |
| HumanPheno | Aplasia/Hypoplasia of fingers | 1.52e-05 | 366 | 18 | 8 | HP:0006265 | |
| HumanPheno | Prominent fingertip pads | 1.62e-05 | 46 | 18 | 4 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 1.93e-05 | 48 | 18 | 4 | HP:0011298 | |
| HumanPheno | Oral aversion | 2.44e-05 | 17 | 18 | 3 | HP:0012523 | |
| HumanPheno | Abnormal male internal genitalia morphology | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 2.50e-05 | 1243 | 18 | 13 | HP:0000022 |
| HumanPheno | Abnormal eyelash morphology | 2.91e-05 | 284 | 18 | 7 | HP:0000499 | |
| HumanPheno | Abnormal internal genitalia | SMARCA4 SOX10 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 2.98e-05 | 1498 | 18 | 14 | HP:0000812 |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | 3.10e-05 | 538 | 18 | 9 | HP:0005927 | |
| HumanPheno | Functional abnormality of male internal genitalia | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 3.17e-05 | 1269 | 18 | 13 | HP:0000025 |
| HumanPheno | Short phalanx of the 5th toe | 3.53e-05 | 3 | 18 | 2 | HP:0100368 | |
| HumanPheno | Abnormal toe morphology | SMARCA4 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 | 4.34e-05 | 893 | 18 | 11 | HP:0001780 |
| HumanPheno | Abnormality of mouth size | 4.55e-05 | 425 | 18 | 8 | HP:0011337 | |
| HumanPheno | Abnormal male reproductive system physiology | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 4.74e-05 | 1314 | 18 | 13 | HP:0012874 |
| HumanPheno | Abnormality of the philtrum | SMARCA4 TCF4 ARID1B FBN1 ZMIZ1 ATN1 RIPPLY2 EP300 MEIS2 ARNT2 | 4.82e-05 | 726 | 18 | 10 | HP:0000288 |
| HumanPheno | Brachydactyly (hand) | 4.95e-05 | 430 | 18 | 8 | HP:0100667 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | 5.09e-05 | 572 | 18 | 9 | HP:0006496 | |
| HumanPheno | Abnormal external nose morphology | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 | 5.56e-05 | 916 | 18 | 11 | HP:0010938 |
| HumanPheno | Scoliosis | SMARCA4 OGDHL TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 | 6.02e-05 | 1122 | 18 | 12 | HP:0002650 |
| HumanPheno | Short 5th finger | 6.08e-05 | 64 | 18 | 4 | HP:0009237 | |
| HumanPheno | Toe deformity | 6.34e-05 | 129 | 18 | 5 | HP:0034398 | |
| HumanPheno | Long eyelashes | 6.34e-05 | 129 | 18 | 5 | HP:0000527 | |
| HumanPheno | Abnormal testis morphology | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 6.43e-05 | 1129 | 18 | 12 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 6.61e-05 | 1132 | 18 | 12 | HP:0011961 |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 6.86e-05 | 66 | 18 | 4 | HP:0006262 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 7.05e-05 | 4 | 18 | 2 | HP:0010343 | |
| HumanPheno | Congenital abnormal hair pattern | 7.24e-05 | 327 | 18 | 7 | HP:0011361 | |
| HumanPheno | Macrostomia | 7.27e-05 | 220 | 18 | 6 | HP:0000181 | |
| HumanPheno | Wide mouth | 7.27e-05 | 220 | 18 | 6 | HP:0000154 | |
| HumanPheno | Azoospermia | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 8.31e-05 | 1157 | 18 | 12 | HP:0000027 |
| HumanPheno | Abnormality of upper lip vermillion | 8.58e-05 | 464 | 18 | 8 | HP:0011339 | |
| HumanPheno | Thin upper lip vermilion | 9.11e-05 | 339 | 18 | 7 | HP:0000219 | |
| HumanPheno | Thin lips | 9.11e-05 | 339 | 18 | 7 | HP:0000213 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 9.37e-05 | 140 | 18 | 5 | HP:0001991 | |
| HumanPheno | Overlapping toe | 9.67e-05 | 72 | 18 | 4 | HP:0001845 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 1.00e-04 | 474 | 18 | 8 | HP:0006493 | |
| HumanPheno | Aplasia of the toes | 1.08e-04 | 74 | 18 | 4 | HP:0011306 | |
| HumanPheno | Absent toe | 1.08e-04 | 74 | 18 | 4 | HP:0010760 | |
| HumanPheno | Deep philtrum | 1.13e-04 | 75 | 18 | 4 | HP:0002002 | |
| HumanPheno | Prominent nasal bridge | 1.16e-04 | 239 | 18 | 6 | HP:0000426 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the 5th toe | 1.17e-04 | 5 | 18 | 2 | HP:0010383 | |
| HumanPheno | Abnormality of the phalanges of the 5th toe | 1.17e-04 | 5 | 18 | 2 | HP:0010342 | |
| HumanPheno | Broad hallux | 1.20e-04 | 76 | 18 | 4 | HP:0010055 | |
| HumanPheno | Abnormal palate morphology | SMARCA4 SOX10 OGDHL TCF4 ARID1B SF3B4 FBN1 ATN1 RIPPLY2 EP300 MEIS2 ARNT2 | 1.24e-04 | 1202 | 18 | 12 | HP:0000174 |
| HumanPheno | Cleft palate | 1.30e-04 | 643 | 18 | 9 | HP:0000175 | |
| HumanPheno | Abnormality of the male genitalia | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 CFAP65 | 1.32e-04 | 1437 | 18 | 13 | HP:0010461 |
| HumanPheno | Abnormal hard palate morphology | 1.36e-04 | 647 | 18 | 9 | HP:0100737 | |
| HumanPheno | Abnormal curvature of the vertebral column | SMARCA4 OGDHL TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 | 1.43e-04 | 1219 | 18 | 12 | HP:0010674 |
| HumanPheno | Prominent interphalangeal joints | 1.75e-04 | 6 | 18 | 2 | HP:0006237 | |
| HumanPheno | Narrow foot | 1.75e-04 | 6 | 18 | 2 | HP:0001786 | |
| HumanPheno | Abnormal lip morphology | SMARCA4 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 1.84e-04 | 1249 | 18 | 12 | HP:0000159 |
| HumanPheno | Abnormal eyebrow morphology | 1.88e-04 | 674 | 18 | 9 | HP:0000534 | |
| HumanPheno | Broad toe | 2.02e-04 | 87 | 18 | 4 | HP:0001837 | |
| HumanPheno | Deeply set eye | 2.09e-04 | 266 | 18 | 6 | HP:0000490 | |
| HumanPheno | Orofacial cleft | 2.36e-04 | 694 | 18 | 9 | HP:0000202 | |
| HumanPheno | Craniofacial cleft | 2.36e-04 | 694 | 18 | 9 | HP:5201015 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the toes | 2.46e-04 | 36 | 18 | 3 | HP:0010173 | |
| HumanPheno | Abnormal penis morphology | 2.89e-04 | 712 | 18 | 9 | HP:0000036 | |
| HumanPheno | Sandal gap | 2.96e-04 | 96 | 18 | 4 | HP:0001852 | |
| HumanPheno | Abnormal columella morphology | 3.08e-04 | 97 | 18 | 4 | HP:0009929 | |
| HumanPheno | Overhanging nasal tip | 3.26e-04 | 8 | 18 | 2 | HP:0011833 | |
| HumanPheno | Abnormal male external genitalia morphology | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 3.48e-04 | 1329 | 18 | 12 | HP:0000032 |
| HumanPheno | Abnormality of the hairline | 3.61e-04 | 294 | 18 | 6 | HP:0009553 | |
| HumanPheno | Abnormal morphology of the great vessels | 3.73e-04 | 736 | 18 | 9 | HP:0030962 | |
| HumanPheno | Long philtrum | 4.01e-04 | 429 | 18 | 7 | HP:0000343 | |
| HumanPheno | Thin vermilion border | 4.25e-04 | 433 | 18 | 7 | HP:0000233 | |
| HumanPheno | Short phalanx of finger | 4.48e-04 | 306 | 18 | 6 | HP:0009803 | |
| HumanPheno | Aplasia involving bones of the extremities | 4.73e-04 | 759 | 18 | 9 | HP:0009825 | |
| HumanPheno | Abnormal external genitalia | SMARCA4 SOX10 TCF4 ARID1B FBN1 ZMIZ1 ATN1 MBD5 RIPPLY2 EP300 MEIS2 ARNT2 | 4.80e-04 | 1372 | 18 | 12 | HP:0000811 |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | 4.82e-04 | 761 | 18 | 9 | HP:0045060 | |
| HumanPheno | Aplasia/Hypoplasia of the phalanges of the hand | 5.61e-04 | 319 | 18 | 6 | HP:0009767 | |
| HumanPheno | Abnormal nasal septum morphology | 5.91e-04 | 115 | 18 | 4 | HP:0000419 | |
| HumanPheno | Abnormal eyelid morphology | SMARCA4 SOX10 OGDHL TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 MBD5 EP300 MEIS2 | 6.23e-04 | 1408 | 18 | 12 | HP:0000492 |
| HumanPheno | Abnormal blood vessel morphology | SMARCA4 SOX10 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 ATN1 RIPPLY2 EP300 MEIS2 | 7.16e-04 | 1201 | 18 | 11 | HP:0033353 |
| HumanPheno | Constipation | 7.21e-04 | 472 | 18 | 7 | HP:0002019 | |
| HumanPheno | Astigmatism | 7.28e-04 | 217 | 18 | 5 | HP:0000483 | |
| HumanPheno | Duodenal ulcer | 7.62e-04 | 12 | 18 | 2 | HP:0002588 | |
| HumanPheno | Aplasia/hypoplasia of the extremities | 7.98e-04 | 813 | 18 | 9 | HP:0009815 | |
| HumanPheno | Abnormal eating behavior | 8.85e-04 | 128 | 18 | 4 | HP:0100738 | |
| HumanPheno | Abnormal hip joint morphology | 9.04e-04 | 490 | 18 | 7 | HP:0001384 | |
| HumanPheno | Low hanging columella | 9.14e-04 | 56 | 18 | 3 | HP:0009765 | |
| HumanPheno | Pes valgus | 9.14e-04 | 56 | 18 | 3 | HP:0008081 | |
| HumanPheno | Abnormal hip bone morphology | 9.37e-04 | 653 | 18 | 8 | HP:0003272 | |
| HumanPheno | Abnormal nasal bridge morphology | SMARCA4 SOX10 TCF4 ARID1B SF3B4 FBN1 ZMIZ1 RIPPLY2 EP300 MEIS2 | 9.67e-04 | 1029 | 18 | 10 | HP:0000422 |
| HumanPheno | Hypoplastic fifth fingernail | 1.05e-03 | 14 | 18 | 2 | HP:0008398 | |
| HumanPheno | Abnormal synovial membrane morphology | 1.06e-03 | 503 | 18 | 7 | HP:0005262 | |
| HumanPheno | Abnormal cerebral ventricle morphology | SMARCA4 SMARCC1 OGDHL TCF4 ARID1B SF3B4 FBN1 ZMIZ1 OGDH EP300 | 1.11e-03 | 1046 | 18 | 10 | HP:0002118 |
| HumanPheno | Brachydactyly | 1.12e-03 | 670 | 18 | 8 | HP:0001156 | |
| HumanPheno | Wide nasal bridge | 1.12e-03 | 508 | 18 | 7 | HP:0000431 | |
| HumanPheno | Short digit | 1.14e-03 | 672 | 18 | 8 | HP:0011927 | |
| HumanPheno | Ventricular septal defect | 1.15e-03 | 510 | 18 | 7 | HP:0001629 | |
| HumanPheno | Abnormal hair pattern | 1.18e-03 | 676 | 18 | 8 | HP:0010720 | |
| HumanPheno | Autistic behavior | 1.21e-03 | 678 | 18 | 8 | HP:0000729 | |
| HumanPheno | Short metatarsal | 1.23e-03 | 62 | 18 | 3 | HP:0010743 | |
| HumanPheno | Neoplasm of the liver | 1.24e-03 | 140 | 18 | 4 | HP:0002896 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | SOX10 CASC3 SMARCD3 TCF4 POU3F1 ARID1B FBN1 ILF3 MBD5 CDH5 RIPPLY2 EP300 MEIS2 ARNT2 | 1.11e-05 | 1269 | 42 | 14 | MP:0011111 |
| Domain | 2-oxogl_dehyd_N | 5.93e-06 | 2 | 46 | 2 | PF16078 | |
| Domain | 2-oxogl_dehyd_N | 5.93e-06 | 2 | 46 | 2 | IPR032106 | |
| Domain | OxoGdeHyase_C | 1.78e-05 | 3 | 46 | 2 | PF16870 | |
| Domain | KGD_C | 1.78e-05 | 3 | 46 | 2 | IPR031717 | |
| Domain | SSDP_DNA-bd | 1.78e-05 | 3 | 46 | 2 | IPR008116 | |
| Domain | 2oxoglutarate_DH_E1 | 1.78e-05 | 3 | 46 | 2 | IPR011603 | |
| Domain | E1_dh | 8.85e-05 | 6 | 46 | 2 | PF00676 | |
| Domain | DH_E1 | 8.85e-05 | 6 | 46 | 2 | IPR001017 | |
| Domain | Transketolase-like_Pyr-bd | 1.65e-04 | 8 | 46 | 2 | IPR005475 | |
| Domain | Transket_pyr | 1.65e-04 | 8 | 46 | 2 | SM00861 | |
| Domain | Transket_pyr | 1.65e-04 | 8 | 46 | 2 | PF02779 | |
| Domain | THDP-binding | 4.55e-04 | 13 | 46 | 2 | IPR029061 | |
| Domain | - | 4.55e-04 | 13 | 46 | 2 | 3.40.50.970 | |
| Domain | Homeodomain-like | 1.30e-03 | 332 | 46 | 5 | IPR009057 | |
| Domain | Bromodomain_CS | 1.86e-03 | 26 | 46 | 2 | IPR018359 | |
| Domain | - | 2.00e-03 | 27 | 46 | 2 | 1.10.260.40 | |
| Domain | LisH | 2.15e-03 | 28 | 46 | 2 | IPR006594 | |
| Domain | LisH | 2.15e-03 | 28 | 46 | 2 | SM00667 | |
| Domain | LISH | 2.15e-03 | 28 | 46 | 2 | PS50896 | |
| Domain | Lambda_DNA-bd_dom | 2.31e-03 | 29 | 46 | 2 | IPR010982 | |
| Domain | BROMODOMAIN_1 | 3.74e-03 | 37 | 46 | 2 | PS00633 | |
| Domain | Bromodomain | 3.94e-03 | 38 | 46 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.58e-03 | 41 | 46 | 2 | PS50014 | |
| Domain | BROMO | 4.80e-03 | 42 | 46 | 2 | SM00297 | |
| Domain | Bromodomain | 4.80e-03 | 42 | 46 | 2 | IPR001487 | |
| Domain | - | 4.80e-03 | 42 | 46 | 2 | 1.20.920.10 | |
| Domain | - | 5.11e-03 | 283 | 46 | 4 | 1.10.10.60 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 5.03e-10 | 42 | 33 | 6 | M48237 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 5.84e-09 | 29 | 33 | 5 | M48076 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.12e-08 | 37 | 33 | 5 | M27797 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 7.64e-08 | 95 | 33 | 6 | M48268 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 6.74e-07 | 137 | 33 | 6 | M48232 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 7.49e-07 | 31 | 33 | 4 | M39522 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.10e-06 | 34 | 33 | 4 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.24e-06 | 35 | 33 | 4 | M47969 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 2.83e-06 | 97 | 33 | 5 | M48262 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.75e-05 | 22 | 33 | 3 | MM1370 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.83e-05 | 142 | 33 | 5 | M48257 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.29e-05 | 24 | 33 | 3 | M13404 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 2.37e-05 | 254 | 33 | 6 | M27131 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 3.14e-05 | 78 | 33 | 4 | M27234 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.49e-05 | 272 | 33 | 6 | M29619 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 4.10e-05 | 29 | 33 | 3 | M29808 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SMARCA4 SMARCC1 SOX10 CASC3 SMARCD3 TCF4 POU3F1 ARID1B ONECUT3 SS18 RIPPLY2 EP300 | 5.35e-05 | 1432 | 33 | 12 | M509 |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.09e-04 | 40 | 33 | 3 | MM14936 | |
| Pathway | WP_THERMOGENESIS | 1.12e-04 | 108 | 33 | 4 | M39746 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 1.21e-04 | 110 | 33 | 4 | M48043 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.08e-04 | 237 | 33 | 5 | M27786 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 2.36e-04 | 10 | 33 | 2 | MM1532 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.30e-04 | 58 | 33 | 3 | M11980 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 3.46e-04 | 12 | 33 | 2 | M22006 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.27e-04 | 153 | 33 | 4 | MM15522 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 6.25e-04 | 16 | 33 | 2 | M27121 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 7.09e-04 | 175 | 33 | 4 | MM14941 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 7.94e-04 | 18 | 33 | 2 | M26942 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 8.49e-04 | 80 | 33 | 3 | M223 | |
| Pathway | PID_REG_GR_PATHWAY | 9.13e-04 | 82 | 33 | 3 | M115 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.09e-03 | 21 | 33 | 2 | M39593 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.20e-03 | 90 | 33 | 3 | M820 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.23e-03 | 91 | 33 | 3 | M27101 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.67e-03 | 26 | 33 | 2 | MM14793 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.93e-03 | 28 | 33 | 2 | M48253 | |
| Pathway | KEGG_CITRATE_CYCLE_TCA_CYCLE | 2.37e-03 | 31 | 33 | 2 | M3985 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 2.52e-03 | 32 | 33 | 2 | M48012 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.54e-03 | 117 | 33 | 3 | M19248 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.60e-03 | 118 | 33 | 3 | M27316 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 2.84e-03 | 34 | 33 | 2 | M39771 | |
| Pathway | REACTOME_GASTRULATION | 3.34e-03 | 129 | 33 | 3 | M46433 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.81e-03 | 277 | 33 | 4 | MM15414 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.92e-03 | 40 | 33 | 2 | MM15060 | |
| Pathway | KEGG_TRYPTOPHAN_METABOLISM | 3.92e-03 | 40 | 33 | 2 | M980 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 4.11e-03 | 283 | 33 | 4 | M13087 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 4.32e-03 | 42 | 33 | 2 | M17541 | |
| Pubmed | 1.08e-11 | 15 | 47 | 5 | 23785148 | ||
| Pubmed | SMARCA4 SMARCC1 SOX10 KDM2B SMARCD3 TCF4 SSBP2 ARID1B FBN1 ZMIZ1 SSBP4 ATN1 SS18 WDR33 PRPF40A EP300 | 2.74e-11 | 1429 | 47 | 16 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SMARCA4 SMARCC1 KDM2B SMARCD3 SSBP2 ARID1B ZMIZ1 ATN1 EP300 BAHCC1 | 3.59e-11 | 351 | 47 | 10 | 38297188 |
| Pubmed | 1.02e-10 | 7 | 47 | 4 | 23540691 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.20e-10 | 23 | 47 | 5 | 30962207 | |
| Pubmed | 2.86e-10 | 27 | 47 | 5 | 29374058 | ||
| Pubmed | 3.40e-10 | 65 | 47 | 6 | 26655900 | ||
| Pubmed | 3.74e-10 | 66 | 47 | 6 | 23275444 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SMARCA4 SMARCC1 ZNF207 SMARCD3 SSBP2 ARID1B SF3B4 ILF3 OGDH ZC3H4 WDR33 PRPF40A MYEF2 | 1.26e-09 | 1082 | 47 | 13 | 38697112 |
| Pubmed | 1.44e-09 | 12 | 47 | 4 | 11734557 | ||
| Pubmed | 1.80e-09 | 157 | 47 | 7 | 30186101 | ||
| Pubmed | AMBN SMARCA4 SMARCC1 SMARCD3 ARID1B ATN1 NCKAP5L SS18 ZC3H4 PRPF40A EP300 MYEF2 BAHCC1 | 1.82e-09 | 1116 | 47 | 13 | 31753913 | |
| Pubmed | 2.07e-09 | 13 | 47 | 4 | 17340523 | ||
| Pubmed | 2.72e-09 | 268 | 47 | 8 | 33640491 | ||
| Pubmed | 3.95e-09 | 15 | 47 | 4 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.95e-09 | 15 | 47 | 4 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.95e-09 | 15 | 47 | 4 | 17920018 | |
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 8.83e-09 | 18 | 47 | 4 | 23698369 | |
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 9.24e-09 | 4 | 47 | 3 | 15170388 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 9.45e-09 | 457 | 47 | 9 | 32344865 | |
| Pubmed | 1.12e-08 | 19 | 47 | 4 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 1.12e-08 | 19 | 47 | 4 | 12110891 | |
| Pubmed | 1.20e-08 | 55 | 47 | 5 | 35945219 | ||
| Pubmed | 2.03e-08 | 61 | 47 | 5 | 20305087 | ||
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 2.54e-08 | 23 | 47 | 4 | 8804307 | |
| Pubmed | 3.05e-08 | 24 | 47 | 4 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 3.05e-08 | 24 | 47 | 4 | 10078207 | |
| Pubmed | 3.05e-08 | 24 | 47 | 4 | 12215535 | ||
| Pubmed | 4.28e-08 | 26 | 47 | 4 | 10778858 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 16230384 | ||
| Pubmed | 5.84e-08 | 152 | 47 | 6 | 38360978 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 5.85e-08 | 28 | 47 | 4 | 12192000 | |
| Pubmed | 5.95e-08 | 399 | 47 | 8 | 35987950 | ||
| Pubmed | 6.78e-08 | 29 | 47 | 4 | 19279220 | ||
| Pubmed | 7.82e-08 | 30 | 47 | 4 | 31043422 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 28369036 | ||
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 8.06e-08 | 7 | 47 | 3 | 9590696 | |
| Pubmed | Target genes of the largest human SWI/SNF complex subunit control cell growth. | 8.06e-08 | 7 | 47 | 3 | 21118156 | |
| Pubmed | The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. | 8.06e-08 | 7 | 47 | 3 | 16687403 | |
| Pubmed | 9.71e-08 | 83 | 47 | 5 | 28794006 | ||
| Pubmed | 1.49e-07 | 35 | 47 | 4 | 32504627 | ||
| Pubmed | 1.87e-07 | 37 | 47 | 4 | 24335282 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 1.93e-07 | 9 | 47 | 3 | 20086098 | |
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 37805104 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.58e-07 | 40 | 47 | 4 | 34585037 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.68e-07 | 486 | 47 | 8 | 30940648 | |
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 2.76e-07 | 10 | 47 | 3 | 16751102 | |
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 34716243 | ||
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 3.79e-07 | 11 | 47 | 3 | 10204490 | |
| Pubmed | 4.58e-07 | 46 | 47 | 4 | 20301533 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SMARCA4 SMARCC1 ZNF207 ARID1B SF3B4 ILF3 SS18 ZC3H4 WDR33 PRPF40A | 4.75e-07 | 954 | 47 | 10 | 36373674 |
| Pubmed | 5.05e-07 | 12 | 47 | 3 | 34336815 | ||
| Pubmed | 5.05e-07 | 12 | 47 | 3 | 33723076 | ||
| Pubmed | 6.55e-07 | 13 | 47 | 3 | 24170322 | ||
| Pubmed | Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. | 6.55e-07 | 13 | 47 | 3 | 11726552 | |
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 8.33e-07 | 14 | 47 | 3 | 36289231 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 8.33e-07 | 14 | 47 | 3 | 8895581 | |
| Pubmed | 8.33e-07 | 14 | 47 | 3 | 30510198 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.03e-06 | 398 | 47 | 7 | 35016035 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 1.04e-06 | 15 | 47 | 3 | 17255939 | |
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 9891079 | ||
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 17640523 | ||
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 14701856 | ||
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 1.28e-06 | 16 | 47 | 3 | 35390516 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.28e-06 | 411 | 47 | 7 | 35182466 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 1.55e-06 | 17 | 47 | 3 | 12368262 | |
| Pubmed | 1.55e-06 | 17 | 47 | 3 | 11078522 | ||
| Pubmed | 1.60e-06 | 425 | 47 | 7 | 24999758 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22245845 | ||
| Pubmed | Chromatin-remodeling factor Brg1 is required for Schwann cell differentiation and myelination. | 1.79e-06 | 2 | 47 | 2 | 22814607 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19279218 | ||
| Pubmed | SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression. | 1.79e-06 | 2 | 47 | 2 | 23874858 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 11030627 | ||
| Pubmed | The SWI/SNF-like BAF complex is essential for early B cell development. | 1.79e-06 | 2 | 47 | 2 | 22427636 | |
| Pubmed | SOX10 modulated SMARCA4 dysregulation alleviates DNA replication stress in cutaneous melanoma. | 1.79e-06 | 2 | 47 | 2 | 36317703 | |
| Pubmed | Regulation of KDM2B and Brg1 on Inflammatory Response of Nasal Mucosa in CRSwNP. | 1.79e-06 | 2 | 47 | 2 | 31041569 | |
| Pubmed | 1.86e-06 | 18 | 47 | 3 | 33323119 | ||
| Pubmed | TIF1gamma controls erythroid cell fate by regulating transcription elongation. | 1.86e-06 | 18 | 47 | 3 | 20603019 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 1.86e-06 | 18 | 47 | 3 | 28068325 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.11e-06 | 154 | 47 | 5 | 16055720 | |
| Pubmed | Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development. | 2.21e-06 | 19 | 47 | 3 | 35173232 | |
| Pubmed | 2.44e-06 | 453 | 47 | 7 | 29656893 | ||
| Pubmed | An epigenetic circuit controls neurogenic programs during neocortex development. | 2.59e-06 | 20 | 47 | 3 | 35020876 | |
| Pubmed | 2.59e-06 | 20 | 47 | 3 | 34220450 | ||
| Pubmed | 2.98e-06 | 73 | 47 | 4 | 22094256 | ||
| Pubmed | 4.47e-06 | 709 | 47 | 8 | 22988430 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 4.52e-06 | 180 | 47 | 5 | 30110629 | |
| Pubmed | 4.59e-06 | 24 | 47 | 3 | 37543677 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 23815551 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32910019 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 17410209 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25746323 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 12079286 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 5.36e-06 | 3 | 47 | 2 | 22426308 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 31197256 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 14603256 | ||
| Pubmed | BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest. | 5.36e-06 | 3 | 47 | 2 | 21520050 | |
| Pubmed | 8.25e-06 | 29 | 47 | 3 | 36800290 | ||
| Pubmed | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. | 8.25e-06 | 29 | 47 | 3 | 15525990 | |
| Pubmed | 8.56e-06 | 549 | 47 | 7 | 38280479 | ||
| Interaction | SS18L1 interactions | 6.29e-11 | 98 | 47 | 8 | int:SS18L1 | |
| Interaction | ERG interactions | SMARCA4 SMARCC1 SOX10 KDM2B SMARCD3 ARID1B ILF3 SS18 PRPF40A EP300 | 8.14e-11 | 223 | 47 | 10 | int:ERG |
| Interaction | SP7 interactions | SMARCA4 SMARCC1 KDM2B SMARCD3 ARID1B ZMIZ1 ATN1 SS18 WDR33 PRPF40A EP300 | 8.26e-11 | 304 | 47 | 11 | int:SP7 |
| Interaction | EGR2 interactions | 1.91e-10 | 171 | 47 | 9 | int:EGR2 | |
| Interaction | TBXT interactions | 2.46e-10 | 116 | 47 | 8 | int:TBXT | |
| Interaction | CRX interactions | 6.25e-09 | 254 | 47 | 9 | int:CRX | |
| Interaction | ETS1 interactions | 1.22e-08 | 121 | 47 | 7 | int:ETS1 | |
| Interaction | MYOD1 interactions | 1.46e-08 | 194 | 47 | 8 | int:MYOD1 | |
| Interaction | BRD7 interactions | SMARCA4 SMARCC1 SOX10 ZNF207 SMARCD3 ARID1B SF3B4 ILF3 SS18 ZC3H4 PRPF40A EP300 | 1.70e-08 | 637 | 47 | 12 | int:BRD7 |
| Interaction | SOX7 interactions | 3.54e-08 | 82 | 47 | 6 | int:SOX7 | |
| Interaction | NUP35 interactions | SMARCC1 ZNF207 ARID1B ILF3 ZMIZ1 ATN1 WDR33 PRPF40A EP300 MYEF2 | 3.95e-08 | 424 | 47 | 10 | int:NUP35 |
| Interaction | SS18 interactions | 5.42e-08 | 88 | 47 | 6 | int:SS18 | |
| Interaction | DPF3 interactions | 8.59e-08 | 95 | 47 | 6 | int:DPF3 | |
| Interaction | DPF1 interactions | 8.59e-08 | 95 | 47 | 6 | int:DPF1 | |
| Interaction | SOX9 interactions | 9.74e-08 | 97 | 47 | 6 | int:SOX9 | |
| Interaction | TLX1 interactions | 1.55e-07 | 175 | 47 | 7 | int:TLX1 | |
| Interaction | TLE3 interactions | 1.81e-07 | 376 | 47 | 9 | int:TLE3 | |
| Interaction | LHX2 interactions | 2.10e-07 | 183 | 47 | 7 | int:LHX2 | |
| Interaction | AR interactions | SMARCA4 SMARCC1 KDM2B TCF4 SSBP2 ARID1B ZMIZ1 ATN1 ZC3H4 WDR33 PRPF40A EP300 MYEF2 | 2.72e-07 | 992 | 47 | 13 | int:AR |
| Interaction | SMARCE1 interactions | 2.98e-07 | 287 | 47 | 8 | int:SMARCE1 | |
| Interaction | FLI1 interactions | 3.25e-07 | 62 | 47 | 5 | int:FLI1 | |
| Interaction | DDIT3 interactions | 3.46e-07 | 120 | 47 | 6 | int:DDIT3 | |
| Interaction | GATA2 interactions | 3.71e-07 | 199 | 47 | 7 | int:GATA2 | |
| Interaction | BCL7A interactions | 4.00e-07 | 123 | 47 | 6 | int:BCL7A | |
| Interaction | PAX7 interactions | 4.20e-07 | 124 | 47 | 6 | int:PAX7 | |
| Interaction | BICRA interactions | 4.80e-07 | 67 | 47 | 5 | int:BICRA | |
| Interaction | PPARG interactions | 4.97e-07 | 307 | 47 | 8 | int:PPARG | |
| Interaction | GCM1 interactions | 5.18e-07 | 68 | 47 | 5 | int:GCM1 | |
| Interaction | ETV4 interactions | 5.57e-07 | 69 | 47 | 5 | int:ETV4 | |
| Interaction | MECP2 interactions | SMARCA4 SMARCC1 ZNF207 SMARCD3 SSBP2 ARID1B SF3B4 ILF3 OGDH ZC3H4 WDR33 PRPF40A EP300 MYEF2 | 8.13e-07 | 1287 | 47 | 14 | int:MECP2 |
| Interaction | PHF10 interactions | 8.22e-07 | 139 | 47 | 6 | int:PHF10 | |
| Interaction | SS18L2 interactions | 9.05e-07 | 76 | 47 | 5 | int:SS18L2 | |
| Interaction | ELF5 interactions | 1.14e-06 | 147 | 47 | 6 | int:ELF5 | |
| Interaction | STK11IP interactions | 1.40e-06 | 83 | 47 | 5 | int:STK11IP | |
| Interaction | IRF1 interactions | 1.40e-06 | 83 | 47 | 5 | int:IRF1 | |
| Interaction | SMARCC2 interactions | 1.42e-06 | 353 | 47 | 8 | int:SMARCC2 | |
| Interaction | NANOG interactions | 1.42e-06 | 481 | 47 | 9 | int:NANOG | |
| Interaction | ARID2 interactions | 1.44e-06 | 153 | 47 | 6 | int:ARID2 | |
| Interaction | MYCN interactions | SMARCA4 SMARCC1 CASC3 ZNF207 SMARCD3 TCF4 ARID1B SF3B4 ILF3 SS18 ZC3H4 PRPF40A EP300 MYEF2 | 1.76e-06 | 1373 | 47 | 14 | int:MYCN |
| Interaction | GSC interactions | 1.78e-06 | 87 | 47 | 5 | int:GSC | |
| Interaction | PAX6 interactions | 1.86e-06 | 366 | 47 | 8 | int:PAX6 | |
| Interaction | PBRM1 interactions | 2.11e-06 | 258 | 47 | 7 | int:PBRM1 | |
| Interaction | EP300 interactions | SMARCA4 SMARCC1 SOX10 OGDHL CASC3 TCF4 SSBP2 PSD2 ILF3 SSBP4 SS18 ZC3H4 PRPF40A EP300 | 2.23e-06 | 1401 | 47 | 14 | int:EP300 |
| Interaction | LHX4 interactions | 2.32e-06 | 166 | 47 | 6 | int:LHX4 | |
| Interaction | BCL7B interactions | 2.75e-06 | 95 | 47 | 5 | int:BCL7B | |
| Interaction | GATA1 interactions | 2.75e-06 | 171 | 47 | 6 | int:GATA1 | |
| Interaction | PLSCR1 interactions | 2.85e-06 | 172 | 47 | 6 | int:PLSCR1 | |
| Interaction | EPAS1 interactions | 2.94e-06 | 173 | 47 | 6 | int:EPAS1 | |
| Interaction | HNF4A interactions | 3.22e-06 | 275 | 47 | 7 | int:HNF4A | |
| Interaction | TEAD1 interactions | 3.25e-06 | 176 | 47 | 6 | int:TEAD1 | |
| Interaction | ARID1A interactions | 3.30e-06 | 276 | 47 | 7 | int:ARID1A | |
| Interaction | ARID1B interactions | 3.36e-06 | 177 | 47 | 6 | int:ARID1B | |
| Interaction | ALG13 interactions | 4.07e-06 | 183 | 47 | 6 | int:ALG13 | |
| Interaction | LHX1 interactions | 4.09e-06 | 103 | 47 | 5 | int:LHX1 | |
| Interaction | ACTL6A interactions | 4.46e-06 | 289 | 47 | 7 | int:ACTL6A | |
| Interaction | SMARCD3 interactions | 4.93e-06 | 107 | 47 | 5 | int:SMARCD3 | |
| Interaction | HNF1B interactions | 5.05e-06 | 190 | 47 | 6 | int:HNF1B | |
| Interaction | EWSR1 interactions | SMARCA4 SMARCC1 CASC3 ZNF207 SSBP2 SF3B4 ILF3 ATN1 PRPF40A EP300 TULP2 | 5.62e-06 | 906 | 47 | 11 | int:EWSR1 |
| Interaction | BCL7C interactions | 7.02e-06 | 115 | 47 | 5 | int:BCL7C | |
| Interaction | FOS interactions | 7.37e-06 | 312 | 47 | 7 | int:FOS | |
| Interaction | BRD9 interactions | 7.64e-06 | 117 | 47 | 5 | int:BRD9 | |
| Interaction | LDB2 interactions | 8.72e-06 | 56 | 47 | 4 | int:LDB2 | |
| Interaction | TPRX2 interactions | 8.72e-06 | 56 | 47 | 4 | int:TPRX2 | |
| Interaction | SMARCA4 interactions | 1.03e-05 | 462 | 47 | 8 | int:SMARCA4 | |
| Interaction | PRMT5 interactions | 1.18e-05 | 471 | 47 | 8 | int:PRMT5 | |
| Interaction | SNRNP70 interactions | SMARCA4 SMARCC1 CASC3 SF3B4 ILF3 ZC3H4 WDR33 PRPF40A PLEKHG3 EP300 MYEF2 | 1.23e-05 | 984 | 47 | 11 | int:SNRNP70 |
| Interaction | TEX13B interactions | 1.32e-05 | 20 | 47 | 3 | int:TEX13B | |
| Interaction | POU3F2 interactions | 1.32e-05 | 20 | 47 | 3 | int:POU3F2 | |
| Interaction | HNRNPC interactions | 1.33e-05 | 634 | 47 | 9 | int:HNRNPC | |
| Interaction | SMARCA2 interactions | 1.44e-05 | 346 | 47 | 7 | int:SMARCA2 | |
| Interaction | DPF2 interactions | 1.52e-05 | 349 | 47 | 7 | int:DPF2 | |
| Interaction | BMI1 interactions | 1.81e-05 | 659 | 47 | 9 | int:BMI1 | |
| Interaction | EYA4 interactions | 2.05e-05 | 243 | 47 | 6 | int:EYA4 | |
| Interaction | TCF12 interactions | 2.39e-05 | 148 | 47 | 5 | int:TCF12 | |
| Interaction | SMARCC1 interactions | 2.82e-05 | 384 | 47 | 7 | int:SMARCC1 | |
| Interaction | RELB interactions | 3.26e-05 | 78 | 47 | 4 | int:RELB | |
| Interaction | GATA4 interactions | 4.34e-05 | 411 | 47 | 7 | int:GATA4 | |
| Interaction | MDC1 interactions | 4.54e-05 | 414 | 47 | 7 | int:MDC1 | |
| Interaction | IRF4 interactions | 4.58e-05 | 85 | 47 | 4 | int:IRF4 | |
| Interaction | PBX4 interactions | 4.79e-05 | 86 | 47 | 4 | int:PBX4 | |
| Interaction | CPSF2 interactions | 5.04e-05 | 173 | 47 | 5 | int:CPSF2 | |
| Interaction | TCAIM interactions | 5.30e-05 | 5 | 47 | 2 | int:TCAIM | |
| Interaction | POU5F1 interactions | 5.50e-05 | 584 | 47 | 8 | int:POU5F1 | |
| Interaction | NEUROD1 interactions | 5.62e-05 | 32 | 47 | 3 | int:NEUROD1 | |
| Interaction | NR1H4 interactions | 5.62e-05 | 32 | 47 | 3 | int:NR1H4 | |
| Interaction | SOX10 interactions | 6.24e-05 | 92 | 47 | 4 | int:SOX10 | |
| Interaction | TAL1 interactions | 6.51e-05 | 93 | 47 | 4 | int:TAL1 | |
| Interaction | SMARCD2 interactions | 6.58e-05 | 183 | 47 | 5 | int:SMARCD2 | |
| Interaction | SOX17 interactions | 7.08e-05 | 95 | 47 | 4 | int:SOX17 | |
| Interaction | GATA3 interactions | 7.29e-05 | 187 | 47 | 5 | int:GATA3 | |
| Interaction | LMX1B interactions | 7.38e-05 | 35 | 47 | 3 | int:LMX1B | |
| Interaction | TRIM33 interactions | 8.00e-05 | 453 | 47 | 7 | int:TRIM33 | |
| Interaction | SMC5 interactions | SMARCA4 SMARCC1 ZNF207 ARID1B SF3B4 ILF3 SS18 ZC3H4 WDR33 PRPF40A | 8.37e-05 | 1000 | 47 | 10 | int:SMC5 |
| Interaction | KLF1 interactions | 8.74e-05 | 37 | 47 | 3 | int:KLF1 | |
| Interaction | ING1 interactions | 9.69e-05 | 103 | 47 | 4 | int:ING1 | |
| Interaction | SIAH2 interactions | 1.01e-04 | 104 | 47 | 4 | int:SIAH2 | |
| Interaction | SNRNP40 interactions | 1.01e-04 | 637 | 47 | 8 | int:SNRNP40 | |
| Interaction | SNRPA interactions | 1.18e-04 | 482 | 47 | 7 | int:SNRPA | |
| Interaction | WBP4 interactions | 1.21e-04 | 109 | 47 | 4 | int:WBP4 | |
| Interaction | NR4A1 interactions | 1.32e-04 | 212 | 47 | 5 | int:NR4A1 | |
| Cytoband | 15q21.1 | 6.68e-04 | 37 | 47 | 2 | 15q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q23 | 1.37e-03 | 53 | 47 | 2 | chr2q23 | |
| GeneFamily | Basic helix-loop-helix proteins | 7.83e-03 | 110 | 22 | 2 | 420 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.57e-02 | 206 | 22 | 2 | 682 | |
| GeneFamily | RNA binding motif containing | 2.73e-02 | 213 | 22 | 2 | 725 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP | 2.91e-05 | 200 | 47 | 5 | M315 | |
| Coexpression | GSE17721_LPS_VS_CPG_6H_BMDC_UP | 2.91e-05 | 200 | 47 | 5 | M3998 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.19e-05 | 259 | 47 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 5.83e-05 | 806 | 47 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 6.59e-05 | 819 | 47 | 9 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 8.23e-05 | 843 | 47 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 1.85e-04 | 50 | 47 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 2.50e-04 | 403 | 47 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 2.71e-04 | 409 | 47 | 6 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.86e-04 | 413 | 47 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 3.01e-04 | 417 | 47 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.37e-04 | 150 | 47 | 4 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.51e-04 | 62 | 47 | 3 | gudmap_developingGonad_e11.5_testes_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 3.91e-04 | 156 | 47 | 4 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 3.91e-04 | 156 | 47 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.00e-04 | 284 | 47 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 4.03e-04 | 65 | 47 | 3 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.41e-04 | 67 | 47 | 3 | gudmap_developingGonad_e12.5_testes_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_200 | 4.81e-04 | 69 | 47 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k5_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_100 | 4.94e-04 | 15 | 47 | 2 | gudmap_developingGonad_e12.5_epididymis_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 4.94e-04 | 166 | 47 | 4 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_100 | 6.38e-04 | 76 | 47 | 3 | gudmap_developingGonad_e12.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_200 | 6.38e-04 | 17 | 47 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k3 | |
| ToppCell | lymphoid-B_cell-pro-B|World / Lineage, cell class and subclass | 2.50e-05 | 161 | 47 | 4 | 23138e579f07d5a6f20d41457cb573b4ac95a4ef | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 2.82e-05 | 166 | 47 | 4 | 13bef304ea3df8e8d2bc376a3287c78220a1b0c6 | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 2.82e-05 | 166 | 47 | 4 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.95e-05 | 168 | 47 | 4 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | Endothelial-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.02e-05 | 169 | 47 | 4 | 95c617143e1fbdd1d55a93ffdcc210e0be37cf2f | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 3.09e-05 | 170 | 47 | 4 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 172 | 47 | 4 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 175 | 47 | 4 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 179 | 47 | 4 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 179 | 47 | 4 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-05 | 179 | 47 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 179 | 47 | 4 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 179 | 47 | 4 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 180 | 47 | 4 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 180 | 47 | 4 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 182 | 47 | 4 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 4.03e-05 | 182 | 47 | 4 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.12e-05 | 183 | 47 | 4 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 183 | 47 | 4 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-05 | 183 | 47 | 4 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | 554c5d812197fbf66bf279fcc953277e926ade15 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.58e-05 | 188 | 47 | 4 | 59f276e23c8380bae57d7ecca3a8b83df4bc150b | |
| ToppCell | Endothelial-B|World / lung cells shred on cell class, cell subclass, sample id | 4.58e-05 | 188 | 47 | 4 | 5959a88728812a5f4cbfa54eddc7a73ccbaa2f68 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 189 | 47 | 4 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 189 | 47 | 4 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.67e-05 | 189 | 47 | 4 | 360f09f46231a83f99d8fa0158b72a38068e1642 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.67e-05 | 189 | 47 | 4 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 190 | 47 | 4 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 190 | 47 | 4 | 3346bfd0474828b3729cffa9f4cc57b04dd30443 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.77e-05 | 190 | 47 | 4 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 190 | 47 | 4 | eae5bcdb8a35f3fba4d25854c1a43f83f80832a2 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 191 | 47 | 4 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | hematopoetic_progenitors-CD34+_CLP|World / Lineage and Cell class | 4.87e-05 | 191 | 47 | 4 | 32f2537c97c9984629d61c6f34a337f555146ad4 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.97e-05 | 192 | 47 | 4 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-05 | 193 | 47 | 4 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-05 | 193 | 47 | 4 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 194 | 47 | 4 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.27e-05 | 195 | 47 | 4 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 196 | 47 | 4 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 5.38e-05 | 196 | 47 | 4 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.49e-05 | 197 | 47 | 4 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc | |
| ToppCell | distal-1-Hematologic-Plasmacytoid_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.49e-05 | 197 | 47 | 4 | 166d47359df9279ea8c3946f10bd3d4b88c95857 | |
| ToppCell | distal-1-Endothelial-Vein|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.60e-05 | 198 | 47 | 4 | eee6cb4fe0e1caf460869d5a0a57c9d259573f10 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.60e-05 | 198 | 47 | 4 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.71e-05 | 199 | 47 | 4 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 199 | 47 | 4 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 199 | 47 | 4 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 5.71e-05 | 199 | 47 | 4 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | B_cell_maturation-pre-B|World / Lineage and Cell class | 5.82e-05 | 200 | 47 | 4 | acb9ad7e3c05ec38e9700fb27b6eed8eaa565689 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-04 | 113 | 47 | 3 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.81e-04 | 134 | 47 | 3 | 932b7dd5781b730dcd2ffe43f6e142e3f8630f67 | |
| ToppCell | mild_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 4.60e-04 | 143 | 47 | 3 | 4698cc877dda9b1ef7d6f18c9adc869ef791b1d8 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.89e-04 | 146 | 47 | 3 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 147 | 47 | 3 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-04 | 147 | 47 | 3 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 5.19e-04 | 149 | 47 | 3 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.39e-04 | 151 | 47 | 3 | 78475027bba9e3026e42493fec8ea630972353bb | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.60e-04 | 153 | 47 | 3 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-04 | 153 | 47 | 3 | 5ac4b97d35c1029a5fc625239f92e35136c4d832 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 5.71e-04 | 154 | 47 | 3 | 8a8c3851888ab86ca2b13ccc042cde1fef8d88f8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.04e-04 | 157 | 47 | 3 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-04 | 157 | 47 | 3 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-04 | 159 | 47 | 3 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.50e-04 | 161 | 47 | 3 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.61e-04 | 162 | 47 | 3 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-04 | 162 | 47 | 3 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-04 | 162 | 47 | 3 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-04 | 163 | 47 | 3 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 6.73e-04 | 163 | 47 | 3 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.73e-04 | 163 | 47 | 3 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.73e-04 | 163 | 47 | 3 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 6.98e-04 | 165 | 47 | 3 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 6.98e-04 | 165 | 47 | 3 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 165 | 47 | 3 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-04 | 166 | 47 | 3 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.10e-04 | 166 | 47 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-04 | 166 | 47 | 3 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-04 | 166 | 47 | 3 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-GMP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.10e-04 | 166 | 47 | 3 | d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-04 | 166 | 47 | 3 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.22e-04 | 167 | 47 | 3 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 7.35e-04 | 168 | 47 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-04 | 168 | 47 | 3 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.35e-04 | 168 | 47 | 3 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.48e-04 | 169 | 47 | 3 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 7.48e-04 | 169 | 47 | 3 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.48e-04 | 169 | 47 | 3 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.61e-04 | 170 | 47 | 3 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-04 | 171 | 47 | 3 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| Computational | Genes in the cancer module 493. | 4.88e-05 | 69 | 32 | 4 | MODULE_493 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.61e-07 | 195 | 47 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | oxoglutarate dehydrogenase deficiency (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:0081326 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.48e-05 | 5 | 47 | 2 | C3281201 | |
| Disease | sitting height ratio | 7.48e-05 | 51 | 47 | 3 | EFO_0007118 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | breast carcinoma | 1.87e-04 | 1019 | 47 | 8 | EFO_0000305 | |
| Disease | Coffin-Siris syndrome | 1.92e-04 | 13 | 47 | 2 | C0265338 | |
| Disease | Cardiovascular Abnormalities | 2.94e-04 | 16 | 47 | 2 | C0243050 | |
| Disease | Cleft Palate | 2.96e-04 | 81 | 47 | 3 | C0008925 | |
| Disease | Feeding difficulties | 3.74e-04 | 18 | 47 | 2 | C0232466 | |
| Disease | Neurodevelopmental Disorders | 4.44e-04 | 93 | 47 | 3 | C1535926 | |
| Disease | eosinophil measurement | 6.88e-04 | 108 | 47 | 3 | EFO_0803540 | |
| Disease | Kallmann Syndrome | 7.88e-04 | 26 | 47 | 2 | C0162809 | |
| Disease | Hirschsprung Disease | 1.12e-03 | 31 | 47 | 2 | C0019569 | |
| Disease | plasma betaine measurement | 1.35e-03 | 34 | 47 | 2 | EFO_0007787 | |
| Disease | Liver Cirrhosis, Experimental | 1.37e-03 | 774 | 47 | 6 | C0023893 | |
| Disease | household income | 1.39e-03 | 304 | 47 | 4 | EFO_0009695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PMTRGPSGHLEPGMG | 1971 | Q09472 | |
| PSGHLEPGMGPTGMQ | 1976 | Q09472 | |
| MMQSGQLGGDPAPHT | 801 | Q9P281 | |
| PPMYGGRGPASHMQH | 901 | Q9P281 | |
| RPGFEGMPHNPAMGG | 286 | Q9NP70 | |
| GMPHNPAMGGDFTLE | 291 | Q9NP70 | |
| PGHLPSPHAMGQGMG | 326 | P54259 | |
| GPSMSPHPSPGGQMH | 881 | Q8NFD5 | |
| NGHMMDGPGENDPDL | 661 | Q6ZPD9 | |
| PGAHGGPGEMAAMIE | 696 | P33151 | |
| DMLPMPGDPTQGTGN | 686 | Q9HBZ2 | |
| MSEAMDQPAGGPGNP | 1 | Q9HCH0 | |
| HGGPPTHPGMTMSAQ | 441 | O14770 | |
| QGVGYNPHMMGDTAP | 1401 | Q6ZU64 | |
| AGPHPGMGDASNHMG | 651 | P15884 | |
| LPHGMEGMGPEHSSA | 766 | Q9ULD0 | |
| DDMGHHLGPDSPLMG | 191 | Q9UJA9 | |
| MAGQPGHMPHGGSSN | 1 | Q9HC98 | |
| RMTPAAGAGHPPMDD | 396 | Q03052 | |
| EMESHPPSQGPGDGE | 16 | O75400 | |
| AESPTPGMAQGMEPG | 126 | Q86VX9 | |
| HGMEGMGPEHSSARP | 781 | Q02218 | |
| MAGPQMGGSAEDHPP | 1 | Q8NHM5 | |
| MCIGPEGDMHDITPG | 176 | Q9H2M3 | |
| GMPNHIHMGAGPPPQ | 491 | O15234 | |
| GMGRGNPEPPVSGEM | 2691 | P35555 | |
| PGFGMGGPMHNEVPP | 621 | Q12906 | |
| SSDHGNFMMPPVGPQ | 466 | Q9P267 | |
| GPLHPAMGMACEAPG | 86 | O60422 | |
| DPTRQQGHPNMGGPM | 161 | P81877 | |
| GHVPDMGSGLMNLPP | 196 | Q9P2K5 | |
| HQARSGPNPPGMESM | 356 | Q5HYW2 | |
| DAHQGLLGMDPPGDM | 546 | A1L390 | |
| GGHAGMGPPPSPMDQ | 101 | P51532 | |
| PPNYSRPHGMGGPNM | 246 | P51532 | |
| PSGARMPHQGAPMGP | 31 | Q6STE5 | |
| PLGAAGHPGMMPHQQ | 981 | Q92922 | |
| DPGGPGMNPVGNSMA | 121 | Q96AW1 | |
| GMAPPGDTAMHVPAG | 11 | P32971 | |
| DAHKSPNMGPNPGMD | 186 | O00295 | |
| MAGGMSAECPEPGPG | 1 | Q6ZMD2 | |
| MAMPNGFHEDGPQGP | 241 | Q9BQI7 | |
| SHNMPSDGMVGGGPP | 101 | Q15532 | |
| SDGMVGGGPPAPHMQ | 106 | Q15532 | |
| MEPSPRAQGHPSMGG | 181 | Q9BWG4 | |
| TPNHAAEAMPDGPGM | 51 | Q5TAB7 | |
| HPGEGSPMSDGNPEH | 216 | P56693 | |
| PGPMGGPMHPDMHPD | 621 | Q9UPT8 | |
| PMPPHGQYGGHHQGM | 421 | O43670 | |
| MHGPQGMQRHPGPHG | 671 | Q9C0J8 | |
| KGDSRGPPNHHMGPM | 956 | Q9C0J8 | |
| FPPGGMPHPGMSQMQ | 296 | Q15427 | |
| PGGTSMNDFMHGPPQ | 906 | Q9ULJ6 | |
| MQPGGTAGPEEAPMR | 1 | Q6ZQT7 |